Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Dec 1;99(5):1051-1058.
doi: 10.1016/j.ijrobp.2017.05.040.

Gastrointestinal Cancers: Timing Is Everything

Smith Apisarnthanarax, Salma K Jabbour, Stanley L Liauw, James D Murphy, Jeffrey R Olsen, Daniel T Chang
Comment

Gastrointestinal Cancers: Timing Is Everything

Smith Apisarnthanarax et al. Int J Radiat Oncol Biol Phys. .
No abstract available

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
This figure shows 94,029 patients with stage I-III rectal adenocarcinoma diagnosed between 2004 and 2013 within the National Cancer Database. Black dots indicate the annual number of patients who did not receive surgery (local excision or proctectomy) divided by the total number of rectal cancer patients in that year. The dotted line shows the trend over time of nonoperative management in rectal cancer. Image courtesy of James D. Murphy.
See this image and copyright information in PMC

Comment on

References

    1. Neoptolemos JP, Palmer DH, Ghaneh P, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): A multicentre, open-label, randomised, phase 3 trial. Lancet 2017;389:1011–1024. - PubMed
    1. Glynne-Jones R, Sebag-Montefiore D, Meadows HM, et al. Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): A post-hoc analysis of randomised controlled phase 3 trial. Lancet Oncol 2017;18:347–356. - PMC - PubMed
    1. Pettersson D, Cedermark B, Holm T, et al. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg 2010;97:580–587. - PubMed
    1. Erlandsson J, Holm T, Pettersson D, et al. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): A multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Lancet Oncol 2017;18:336–346. - PubMed
    1. Lefevre JH, Mineur L, Kotti S, et al. Effect of interval (7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer: A multicenter, randomized, controlled trial (GRECCAR-6). J Clin Oncol 2016;34:3773–3780. - PubMed

LinkOut - more resources